Additionally, the company promoted Holger Wesche, PhD, from senior vice president, research to chief scientific officer.
Erbez previously served as chief business officer and chief financial officer of Zosano Pharma, a therapeutics company focused on migraine, from 2016 through 2018.
She also served as chief financial officer and executive vice president of Asterias Biotherapeutics and chief financial officer, secretary and treasurer of Raptor Pharmaceuticals, where she helped to navigate the company through a growth period that included its first drug approval and subsequent commercial launch.
Prior to Raptor, Erbez was a managing director, Healthcare Investment Banking at Collins Stewart, a Founder and Managing director at Beal Advisors, and a senior level investment banker at Jefferies and company, and Cowen and company. She has also held positions at the investment banks Hambrecht and Quist and Alex. Brown and Sons.
Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business